{"filing":{"accession_number":"0001213900-26-085653","cik":"0002108359","ticker":null,"company_name":"BioKey (Cayman), Inc.","form":"8-K","filing_date":"2026-08-05","report_date":"2026-08-05","primary_document":"ea0300506-8k_biokey.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/2108359/000121390026085653/ea0300506-8k_biokey.htm"},"events":[{"id":24788,"run_id":22478,"accession_number":"0001213900-26-085653","anchor_item_number":"8.01","event_type":"dividend_distribution","event_domain":"financial","is_material":true,"confidence":0.85,"summary":"The disclosure concerns a postponement of a previously announced distribution of BioKey's ordinary shares to ABVC stockholders. Although the distribution has been delayed rather than completed, the event centers on a material capital distribution (spin-off) with a fixed distribution ratio of 0.169464 shares per ABVC share. The postponement itself is material to investors as it affects the timing and mechanics of a significant corporate action, and the filing explicitly addresses the distribution date, ex-dividend date, and record date—hallmarks of a dividend/distribution event.","company_name":"BioKey (Cayman), Inc.","ticker":null,"filing_date":"2026-08-05","form":"8-K","submitted_at":null,"items":[{"id":25460,"accession_number":"0001213900-26-085653","item_number":"8.01","item_title":"Other Events.","event_type":"dividend_distribution","event_domain":"financial","is_material":true,"confidence":0.85,"reasoning":"The disclosure concerns a postponement of a previously announced distribution of BioKey's ordinary shares to ABVC stockholders. Although the distribution has been delayed rather than completed, the event centers on a material capital distribution (spin-off) with a fixed distribution ratio of 0.169464 shares per ABVC share. The postponement itself is material to investors as it affects the timing and mechanics of a significant corporate action, and the filing explicitly addresses the distribution date, ex-dividend date, and record date—hallmarks of a dividend/distribution event.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-07T02:21:44.912963+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":25460,"accession_number":"0001213900-26-085653","item_number":"8.01","item_title":"Other Events.","event_type":"dividend_distribution","event_domain":"financial","is_material":true,"confidence":0.85,"reasoning":"The disclosure concerns a postponement of a previously announced distribution of BioKey's ordinary shares to ABVC stockholders. Although the distribution has been delayed rather than completed, the event centers on a material capital distribution (spin-off) with a fixed distribution ratio of 0.169464 shares per ABVC share. The postponement itself is material to investors as it affects the timing and mechanics of a significant corporate action, and the filing explicitly addresses the distribution date, ex-dividend date, and record date—hallmarks of a dividend/distribution event.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-07T02:21:44.912963+00:00","company_name":"BioKey (Cayman), Inc.","ticker":null,"filing_date":"2026-08-05"}]}